Elanco Animal Health Incorporated Insider Trading

ELAN

Cluster buy

5 insiders bought $1.47M of their own stock in 14 days.

Open-market purchases by executives and directors between Aug 7 and Aug 20. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

+$2.51M

11 buys · 1 sale

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

7 / 1

executives and directors

Last open-market buy

Aug 2026

Aug 20, 2026

Get an email when ELAN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 15	Timothy J Bettington See Remarks	Sold10b5-1 plan	4,350	$23.00	100K	3.0%	Form 4
Aug 20	Lawrence Erik Kurzius Director	Bought	40,000	$23.40	936K	27%	Form 4
Aug 18	Shiv O'Neill GC and Corp Sec	Bought	3,998	$23.58	94K	4.8%	Form 4
Aug 12	Michael J Harrington Director	Bought	5,000	$21.82	109K	4.0%	Form 4
Aug 7	Robert M Vanhimbergen EVP and CFO	Bought	4,200	$23.08	97K	3.2%	Form 4
Aug 7	Paul Herendeen Director	Bought	10,000	$23.69	237K	9.8%	Form 4
May 15	Rajeev A. Modi See Remarks	Bought	4,911	$20.35	100K	3.2%	Form 4
May 15	Jeffrey N Simmons President, CEO and Director	Bought	4,971	$20.09	100K	0.2%	Form 4
Dec 12, 2025	Lawrence Erik Kurzius Director	Bought	10,000	$21.30	213K	8.2%	Form 4
Dec 11, 2025	Rajeev A. Modi See Remarks	Bought	4,500	$21.33	96K	3.8%	Form 4
Dec 11, 2025	Robert M Vanhimbergen EVP and CFO	Bought	6,950	$21.64	150K	5.9%	Form 4
Dec 11, 2025	Jeffrey N Simmons President, CEO and Director	Bought	22,000	$21.75	479K	1.1%	Form 4
Mar 7, 2025 – Mar 11, 2025	Lawrence Erik Kurzius Director	Bought 2 parts	20,000	$10.55 average	211K	22%	Form 4
Mar 5, 2025	R David Hoover Director	Bought	25,000	$10.90	273K	8.4%	Form 4

Oct 1510b5-1 plan
Timothy J Bettington
See Remarks · sold 4,350 at $23.00
100K
3.0% of stake
Aug 20
Lawrence Erik Kurzius
Director · bought 40,000 at $23.40
936K
27% of stake
Aug 18
Shiv O'Neill
GC and Corp Sec · bought 3,998 at $23.58
94K
4.8% of stake
Aug 12
Michael J Harrington
Director · bought 5,000 at $21.82
109K
4.0% of stake
Aug 7
Robert M Vanhimbergen
EVP and CFO · bought 4,200 at $23.08
97K
3.2% of stake
Aug 7
Paul Herendeen
Director · bought 10,000 at $23.69
237K
9.8% of stake
May 15
Rajeev A. Modi
See Remarks · bought 4,911 at $20.35
100K
3.2% of stake
May 15
Jeffrey N Simmons
President, CEO and Director · bought 4,971 at $20.09
100K
0.2% of stake
Dec 12, 2025
Lawrence Erik Kurzius
Director · bought 10,000 at $21.30
213K
8.2% of stake
Dec 11, 2025
Rajeev A. Modi
See Remarks · bought 4,500 at $21.33
96K
3.8% of stake
Dec 11, 2025
Robert M Vanhimbergen
EVP and CFO · bought 6,950 at $21.64
150K
5.9% of stake
Dec 11, 2025
Jeffrey N Simmons
President, CEO and Director · bought 22,000 at $21.75
479K
1.1% of stake
Mar 7, 2025 – Mar 11, 2025
Lawrence Erik Kurzius
Director · bought 20,000 at avg $10.55
211K
22% of stake
Mar 5, 2025
R David Hoover
Director · bought 25,000 at $10.90
273K
8.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ELAN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ELAN

CompareIntrinsic value

JAZZJazz Pharmaceuticals plc

$234.66+2.14%58

ONCBeOne Medicines Ltd.

$377.78+6.42%65

PRGOPerrigo Company plc

$15.83+0.83%17

OGNOrganon & Co.

$13.83-0.14%28

ALNYAlnylam Pharmaceuticals Inc

$161.08+0.74%81

BMRNBiomarin Pharmaceutical Inc.

$57.13+2.64%47

UTHRUnited Therapeutics Corporation

$608.49+1.19%78

AMRXAmneal Pharmaceuticals Inc.

$19.95-1.29%57

Held by ETFs

ELAN is in 140 US ETFs. The largest of them, with ELAN's weight in each:

Spot a number that looks wrong? Check it in ELAN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ELAN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.